Loading...

Oncotarget | Interview with Dr. Alex Toker & Dr. Maria Mancini, Harvard Medical School

635 views

Loading...

Loading...

Transcript

The interactive transcript could not be loaded.

Loading...

Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Published on Apr 7, 2016

Full text - http://bit.ly/1qobAH5

Oncotarget | Interview with Dr. Alex Toker & Dr. Maria Mancini from Beth Israel Deaconess Medical Center with Harvard Medical School talking about their featured cover paper in Oncotarget - "Oncogenic AKT1(E17K) mutation induces mammary hyperplasia but prevents HER2-driven tumorigenesis"

Facebook - http://bit.ly/2xznxjV
Twitter - http://bit.ly/2xzWvsu
LinkedIn - http://bit.ly/2xzJ6kc
Pintrest - http://bit.ly/2xzX8SS
Reddit - http://bit.ly/2hoxI0N

www.Oncotarget.com

Oncotarget is a weekly, peer-reviewed, open access Journal covering research on all aspects of oncology. Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types and even tissues that can be viewed as targets relevant to cancer and other diseases as well. The term was introduced in the inaugural Editorial "Introducing OncoTarget" http://bit.ly/Introducing-Oncotarget

Loading...

When autoplay is enabled, a suggested video will automatically play next.

Up next


to add this to Watch Later

Add to

Loading playlists...